The market is predicted to rise from USD 8.3 Bn in 2026 to USD 12.3 Bn by 2033.
The transcatheter aortic valve replacement surgery has shown a 90% success rate.
North America market led with a revenue share of 49.1% in 2025.
Boston Scientific Corporation, Bracco Group, Braile Biomedica, Direct Flow Medical, and JenaValve are some of the leading companies in the THVR repair market.
Hospitals are the leading end user of THVR among other end users. It dominated the market with a 66.2% share in 2025.